In this CE activity, experts in the field review the latest imaging tools for the early diagnosis and monitoring of disease progression; evaluate clinical and imaging characteristics associated with disease progression in different phenotypes; and assess individualized treatment selection for patients with GA secondary to age-related macular degeneration (AMD). Rapid-Fire Roundtable discussion will further examine practical methods and procedures that can facilitate the optimal implementation of imaging modalities and therapies into the management of patient with GA secondary to AMD.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/retinacme/age-related-macular-degeneration/20241115/ga-secondary-to-amd-optimizing-long-term-outcomes-through-refined-treatment-selection/overview
- Start Date: 2024-11-28 06:00:00
- End Date: 2024-11-28 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Apellis Pharmaceuticals, Inc. - Amount: 27813.33 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest